product listing agreement – Benefits Canada.com https://www.benefitscanada.com Canada's most influential pension and benefits publication for decision-makers Fri, 03 May 2024 14:46:09 +0000 en-US hourly 1 https://wordpress.org/?v=4.9.8 Quebec biosimilars policy could cut drug costs for plan sponsors: expert https://www.benefitscanada.com/benefits/health-benefits/quebec-biosimilars-policy-could-cut-drug-costs-for-plan-sponsors-expert/ Thu, 07 Apr 2022 13:00:13 +0000 https://www.benefitscanada.com/?p=119265 Changes to Quebec’s policy on the use of biosimilars in its public drug plan could result in savings for private benefits plans, says one expert. On April 13, 2022, the Régie de l’assurance maladie du Québec will delist certain biologic drugs from its formulary, requiring patients covered by the plan to switch to a biosimilar […]

The post Quebec biosimilars policy could cut drug costs for plan sponsors: expert appeared first on Benefits Canada.com.

]]> 2022 Drug Plan Trends Report: High-cost drugs, DEI shaping drug plans https://www.benefitscanada.com/archives_/benefits-canada-archive/2022-drug-plan-trends-report-how-high-cost-drugs-dei-are-shaping-drug-plans/ Fri, 18 Mar 2022 12:55:41 +0000 https://www.benefitscanada.com/?p=118158 This month marks the second anniversary of the beginning of the coronavirus pandemic, a 24-month span that has had profound effects on the health of benefits plan members and the status and structure of their plans. For drug plans in particular, several trends have come to light — or have accelerated — during the course […]

The post 2022 Drug Plan Trends Report: High-cost drugs, DEI shaping drug plans appeared first on Benefits Canada.com.

]]>